J. Gorski

发表

The effect of hormone replacement therapy on CYP3A activity

S. Wrighton, J. Gorski, Zaiqi Wang, 2000, Clinical pharmacology and therapeutics.

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin

J. Gorski, B. Haehner‐Daniels, S. Hall, 1998, Clinical pharmacology and therapeutics.

The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity

David A. Flockhart, Zeruesenay Desta, Stephen D. Hall, 2003, Journal of Pharmacology and Experimental Therapeutics.

Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin.

J. Gorski, B. Haehner‐Daniels, S. Hall, 2002, Drug metabolism and disposition: the biological fate of chemicals.

Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer

Christie M. Orschell, A. Srirangam, Lang Li, 2006, Clinical Cancer Research.

Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6

J. Tanus-Santos, D. Flockhart, J. Gorski, 2003, The Pharmacogenomics Journal.

Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: A comparison with nonalcoholics

N. Chalasani, J. Gorski, S. Hall, 2005, Hepatology.

Inhibition of Human Intestinal Wall Metabolism by Macrolide Antibiotics: Effect of Clarithromycin on Cytochrome P450 3A4/5 Activity and Expression

N. Chalasani, T. Skaar, J. Gorski, 2005, Clinical pharmacology and therapeutics.

Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N‐demethylation

D. Jones, J. Gorski, S. Hall, 1996, Clinical pharmacology and therapeutics.

Navajo neuropathy: Relation to MDR3 mRNA deficiency

V. Stanton, J. Gorski, S. Hall, 2002, Hepatology.

The effect of short‐ and long‐term administration of verapamil on the disposition of cytochrome P450 3A and P‐glycoprotein substrates

J. Gorski, Zaiqi Wang, S. Hall, 2006, Clinical pharmacology and therapeutics.

The Effect of Echinacea (Echinacea purpurea Root) on Cytochrome P450 Activity in Vivo

Shiew-Mei Huang, J. Gorski, S. Hall, 2004, Clinical pharmacology and therapeutics.

Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping

H. Greenberg, J. Gorski, S. Stoch, 2013, Drug metabolism and drug interactions.

Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts

N. Chalasani, J. Gorski, S. Hall, 2001, Hepatology.

In vivo effect of clarithromycin on multiple cytochrome P450s.

J. Gorski, B. Haehner‐Daniels, S. Hall, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Drug Interactions with St. John's Wort and Echinacea

J. Gorski, 2006 .

Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity.

D. Jones, J. Gorski, S. Hall, 1996, Journal of chromatography. B, Biomedical applications.

DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE

Lang Li, J. Gorski, S. Hall, 2005, Drug Metabolism and Disposition.

Role of duration of diuretic effect in preventing sodium retention

J. Gorski, D. Brater, D. Rudy, 1997, Clinical pharmacology and therapeutics.

Drug-induced QT Prolongation in Cirrhotic Patients With Transjugular Intrahepatic Portosystemic Shunt

N. Chalasani, J. Gorski, S. Hall, 2011, Journal of clinical gastroenterology.

Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.

J. Gorski, D. Brater, R. Agarwal, 2000, Journal of the American Society of Nephrology : JASN.

Effect of cirrhosis and liver transplantation on the gender difference in QT interval.

Lang Li, N. Chalasani, D. Flockhart, 2005, The American journal of cardiology.

Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.

N. Chalasani, J. Gorski, D. Brater, 2001, Journal of the American Society of Nephrology : JASN.

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

Shiew-Mei Huang, L. Lesko, J. Gorski, 2001, Clinical pharmacology and therapeutics.

The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity.

S. Wrighton, J. Gorski, S. Hall, 2002, British journal of clinical pharmacology.

Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.

Lang Li, J. Gorski, Zaiqi Wang, 2003, British journal of clinical pharmacology.

Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.

N. Chalasani, J. Gorski, D. Brater, 2001, Transactions of the American Clinical and Climatological Association.

Bimodal distribution of renal cytochrome P450 3A activity in humans.

P. Watkins, S. Wrighton, J. Gorski, 1996, Molecular pharmacology.

In vivo effects of interleukin‐10 on human cytochrome P450 activity

J. Gorski, S. Hall, D. Cutler, 2000, Clinical pharmacology and therapeutics.

Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.

A. Li, J. Gorski, S. Hall, 1997, Chemico-biological interactions.

The interaction between St John's wort and an oral contraceptive

Shiew-Mei Huang, J. Gorski, Zaiqi Wang, 2003, Clinical pharmacology and therapeutics.

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

N. Chalasani, D. Crabb, J. Gorski, 2003, Hepatology.

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

S D Hall, S. Wrighton, D. Jones, 1994, Biochemical pharmacology.

Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.

D. Jones, J. Gorski, S. Hall, 1999, The Journal of pharmacology and experimental therapeutics.

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin

N. Chalasani, J. Gorski, S. Hall, 2013, European Journal of Clinical Pharmacology.

Interaction between midazolam and clarithromycin in the elderly.

J. Gorski, S. Hall, S. Quinney, 2008, British journal of clinical pharmacology.

The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity

W. Ambrosius, J. Gorski, B. Haehner‐Daniels, 2003, Clinical pharmacology and therapeutics.

Intrapericardial Ibutilide Administration Fails to Terminate Pacing-Induced Sustained Atrial Fibrillation in Dogs

D. Zipes, J. Gorski, R. Mehra, 2004, Cardiovascular Drugs and Therapy.

Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.

S. Wrighton, D. Jones, J. Gorski, 1999, Xenobiotica; the fate of foreign compounds in biological systems.

Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.

S. Wrighton, D. Jones, J. Gorski, 1994, Biochemical pharmacology.

Intramuscular Haloperidol or Lorazepam and QT Intervals in Schizophrenia

D. Greenblatt, S. Preskorn, D. Flockhart, 2004, Journal of clinical pharmacology.

Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.

S. Wrighton, D. Jones, J. Gorski, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Effects of Commonly Administered Agents and Genetics on Nebivolol Pharmacokinetics: Drug‐Drug Interaction Studies

J. Gorski, C. Lindamood, S. Ortiz, 2011, Journal of clinical pharmacology.

Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.

A. Struthers, J. Gorski, D. Brater, 2004, British journal of clinical pharmacology.

Indinavir impairs endothelial function in healthy HIV-negative men.

J. Klaunig, S. Shankar, J. Gorski, 2005, American heart journal.

STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE

Jenny Y Chien, S. Wrighton, J. Chien, 2006, Drug Metabolism and Disposition.

Insulin sensitivity is preserved despite disrupted endothelial function.

R. Considine, S. Shankar, J. Gorski, 2006, American journal of physiology. Endocrinology and metabolism.

Semiphysiologically Based Pharmacokinetic Models for the Inhibition of Midazolam Clearance by Diltiazem and Its Major Metabolite

Sara K Quinney, J. Gorski, S. Hall, 2009, Drug Metabolism and Disposition.

Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin

Sara K. Quinney, Lang Li, Stephen D. Hall, 2010, Drug Metabolism and Disposition.

DMD 28746 1 Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP 3 A by Clarithromycin

Lang Li, J. Gorski, S. Hall, 2009 .

Severe Impairment of Endothelial Function with the HIV-1 Protease Inhibitor Indinavir is not Mediated by Insulin Resistance in Healthy Subjects

Changyu Shen, J. Gorski, M. Dubé, 2008, Cardiovascular Toxicology.

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers

J. Gorski, M. Liu, W. Xue, 2023, Journal of asthma and allergy.

N. Chalasani, J. Gorski, R. Galinsky, 2002 .